172 related articles for article (PubMed ID: 8282345)
21. Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells.
Natarajan R; Yang DC; Lanting L; Nadler JL
Endocrine; 2002 Aug; 18(3):295-301. PubMed ID: 12450322
[TBL] [Abstract][Full Text] [Related]
22. p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.
Touyz RM; He G; El Mabrouk M; Schiffrin EL
Hypertension; 2001 Feb; 37(2 Pt 2):574-80. PubMed ID: 11230337
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
Watts SW; Florian JA; Monroe KM
J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
[TBL] [Abstract][Full Text] [Related]
24. Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells.
Louis S; Saward L; Zahradka P
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H746-56. PubMed ID: 21622819
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice.
Ruiz-Ortega M; Lorenzo O; Rupérez M; Suzuki Y; Egido J
Nephrol Dial Transplant; 2001; 16 Suppl 1():27-33. PubMed ID: 11369817
[TBL] [Abstract][Full Text] [Related]
26. Involvement of cysteinyl leukotrienes in angiotensin II-induced contraction in isolated aortas from transgenic (mRen-2)27 rats.
Stanke-Labesque F; Hardy G; Vergnaud S; Devillier P; Peoc'h M; Randon J; Bricca G; Caron F; Cracowski JL; Bessard G
J Hypertens; 2002 Feb; 20(2):263-72. PubMed ID: 11821711
[TBL] [Abstract][Full Text] [Related]
27. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.
Ko Y; Görg A; Appenheimer M; Wieczorek AJ; Düsing R; Vetter H; Sachinidis A
Eur J Pharmacol; 1992 Oct; 227(2):215-9. PubMed ID: 1426030
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis.
Rupérez M; Lorenzo O; Blanco-Colio LM; Esteban V; Egido J; Ruiz-Ortega M
Circulation; 2003 Sep; 108(12):1499-505. PubMed ID: 12952842
[TBL] [Abstract][Full Text] [Related]
29. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
Dunn FW; Roux MH; Farhadian F; Sabri K; Ossart C; Samuel JL; Rappaport L; Hamon G
J Pharmacol Exp Ther; 1997 Jan; 280(1):447-53. PubMed ID: 8996227
[TBL] [Abstract][Full Text] [Related]
30. 20-Hydroxyeicosatetraenoic acid mediates angiotensin ii-induced phospholipase d activation in vascular smooth muscle cells.
Parmentier JH; Muthalif MM; Nishimoto AT; Malik KU
Hypertension; 2001 Feb; 37(2 Pt 2):623-9. PubMed ID: 11230346
[TBL] [Abstract][Full Text] [Related]
31. A long-term receptor stimulation is requisite for angiotensin II-dependent DNA synthesis in vascular smooth muscle cells from spontaneously hypertensive rats.
Itazaki K; Hara M; Itoh N; Fujimoto M
Eur J Pharmacol; 1995 Nov; 291(3):417-25. PubMed ID: 8719428
[TBL] [Abstract][Full Text] [Related]
32. Macrophage 12(S)-HETE Enhances Angiotensin II-Induced Contraction by a BLT2 (Leukotriene B
Kriska T; Herrnreiter A; Pfister SL; Adebesin A; Falck JR; Campbell WB
Hypertension; 2022 Jan; 79(1):104-114. PubMed ID: 34784723
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
[TBL] [Abstract][Full Text] [Related]
34. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
[TBL] [Abstract][Full Text] [Related]
35. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid.
Zhu M; Natarajan R; Nadler JL; Moore JM; Gelband CH; Sumners C
J Neurophysiol; 2000 Nov; 84(5):2494-501. PubMed ID: 11067992
[TBL] [Abstract][Full Text] [Related]
37. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
Muthalif MM; Benter IF; Karzoun N; Fatima S; Harper J; Uddin MR; Malik KU
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12701-6. PubMed ID: 9770549
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.
Stanke-Labesque F; Devillier P; Bedouch P; Cracowski JL; Chavanon O; Bessard G
Cardiovasc Res; 2000 Aug; 47(2):376-83. PubMed ID: 10946074
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
[TBL] [Abstract][Full Text] [Related]
40. ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells.
Corriu C; André P; Schott C; Michel M; Stoclet JC
Am J Physiol; 1994 Feb; 266(2 Pt 2):H631-6. PubMed ID: 8141364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
